IGC Pharma, Inc. (IGC)Healthcare | Biotechnology | Potomac, United States | NYSE American
0.27 USD
-0.01
(-2.243%) ⇩
(July 13, 2026, 4 p.m.
EDT)
After hours: 0.26 0.00 (-0.002%) ⇩ (July 13, 2026, 7:52 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 4:03 a.m. EDT
The investment case here is defined by a stark disconnect between the company's deteriorating fundamentals and aggressive insider buying. While the business is in freefall—reporting negative revenue growth, burning cash, and posting double-digit losses on equity—the CEO and CFO have just converted over $1.15 million in debt into stock and purchased additional shares. This insider activity is the only signal suggesting management believes the current price is a floor, likely driven by upcoming clinical data or a strategic pivot. However, the long-term outlook remains bleak; the stock has lost nearly one-third of its value over the last nine years, with the most recent annual performance showing another decline. The balance sheet is fragile, with debt significantly outweighing equity and operating cash flows deeply negative. Consequently, while the insider purchases create a short-term speculative thesis based on potential catalysts, the underlying business quality has eroded to the point where it cannot support a long-term hold without significant turnaround proof. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.077466 |
| AutoETS | 0.085490 |
| MSTL | 0.093718 |
| AutoTheta | 0.122442 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 49% |
| H-stat | 7.93 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.554 |
| Excess Kurtosis | -0.52 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 15.128 |
| Revenue per Share | 0.013 |
| Market Cap | 27,750,962 |
| Forward P/E | -3.13 |
| Beta | 0.46 |
| Previous Name | India Globalization Capital, Inc. |
| Website | https://igcpharma.com |
As of July 11, 2026, 4:03 a.m. EDT: Speculators are positioning asymmetrically for a massive upside move, with heavy call volume and open interest concentrated at strikes far above the current price (e.g., $2.50 and $5.00), while put activity is minimal and focused on deep out-of-the-money strikes. This suggests a speculative bet on a clinical catalyst or restructuring event rather than a hedging strategy against downside risk.
| Attribute | Value |
|---|---|
| 52 Week Change | -0.2702703 |
| Address1 | 10,224 Falls Road |
| All Time High | 71.1 |
| All Time Low | 0.14 |
| Ask | 0.0 |
| Ask Size | 600 |
| Average Daily Volume10 Day | 442,750 |
| Average Daily Volume3 Month | 1,275,368 |
| Average Volume | 1,275,368 |
| Average Volume10Days | 442,750 |
| Beta | 0.456 |
| Bid | 0.0 |
| Bid Size | 5,800 |
| Book Value | 0.062 |
| City | Potomac |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.2659 |
| Current Ratio | 1.324 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 0.2805 |
| Day Low | 0.2611 |
| Debt To Equity | 15.128 |
| Display Name | IGC Pharma |
| Earnings Timestamp End | 1,754,942,400 |
| Earnings Timestamp Start | 1,754,424,000 |
| Ebitda | -7,524,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -3.629 |
| Enterprise To Revenue | 24.688 |
| Enterprise Value | 27,305,282 |
| Eps Current Year | -0.09 |
| Eps Forward | -0.085 |
| Eps Trailing Twelve Months | -0.06 |
| Esg Populated | 0 |
| Exchange | ASE |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.289 |
| Fifty Day Average Change | -0.023100019 |
| Fifty Day Average Change Percent | -0.07993086 |
| Fifty Two Week Change Percent | -27.027029 |
| Fifty Two Week High | 0.5 |
| Fifty Two Week High Change | -0.23410001 |
| Fifty Two Week High Change Percent | -0.46820003 |
| Fifty Two Week Low | 0.24 |
| Fifty Two Week Low Change | 0.025899991 |
| Fifty Two Week Low Change Percent | 0.10791663 |
| Fifty Two Week Range | 0.24 - 0.5 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,148,477,400,000 |
| Float Shares | 86,077,532 |
| Forward Eps | -0.085 |
| Forward P E | -3.128235 |
| Free Cashflow | -2,521,375 |
| Full Exchange Name | NYSE American |
| Full Time Employees | 70 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.46203 |
| Gross Profits | 511,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.1338 |
| Held Percent Institutions | 0.21705 |
| Implied Shares Outstanding | 104,366,170 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ir Website | http://www.indiaglobalcap.com/stockprice.php |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,743,379,200 |
| Last Split Date | 1,366,329,600 |
| Last Split Factor | 1:10 |
| Long Business Summary | IGC Pharma, Inc., a clinical stage pharmaceutical company, develops novel therapeutic candidates for neuropsychiatric and neurodegenerative disorders, with a primary focus on Alzheimer's disease in the United States and Colombia. The company's lead product is IGC-AD1 that is in Phase II clinical trial for the treatment of agitation in dementia due to Alzheimer's. Its pre-clinical stage product candidate includes TGR-63 and IGC-M3 to treat Alzheimer's disease. In addition, the company develops MINT-AD, an AI-driven assistant for healthcare providers. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. IGC Pharma, Inc. was incorporated in 2005 and is headquartered in Potomac, Maryland. |
| Long Name | IGC Pharma, Inc. |
| Market | us_market |
| Market Cap | 27,750,962 |
| Market State | PREPRE |
| Max Age | 86,400 |
| Message Board Id | finmb_22356580 |
| Most Recent Quarter | 1,774,915,200 |
| Name Change Date | 2,026-07-13 |
| Net Income To Common | -6,446,000 |
| Next Fiscal Year End | 1,774,915,200 |
| Non Diluted Market Cap | 27,750,964 |
| Number Of Analyst Opinions | 2 |
| Open | 0.265 |
| Operating Cashflow | -5,544,000 |
| Operating Margins | -7.22713 |
| Payout Ratio | 0.0 |
| Phone | 301 983 0998 |
| Post Market Change | -0.0022999942 |
| Post Market Change Percent | -0.8649847 |
| Post Market Price | 0.2636 |
| Post Market Time | 1,783,986,758 |
| Prev Name | India Globalization Capital, Inc. |
| Previous Close | 0.272 |
| Price Eps Current Year | -2.9544442 |
| Price Hint | 4 |
| Price To Book | 4.2887096 |
| Price To Sales Trailing12 Months | 25.091286 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.787 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.00610003 |
| Regular Market Change Percent | -2.24266 |
| Regular Market Day High | 0.2805 |
| Regular Market Day Low | 0.2611 |
| Regular Market Day Range | 0.2611 - 0.2805 |
| Regular Market Open | 0.265 |
| Regular Market Previous Close | 0.272 |
| Regular Market Price | 0.2659 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 508,736 |
| Return On Assets | -0.50312 |
| Return On Equity | -0.83341 |
| Revenue Growth | -0.039 |
| Revenue Per Share | 0.013 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 104,366,170 |
| Shares Percent Shares Out | 0.0046 |
| Shares Short | 484,812 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 1,175,372 |
| Short Name | IGC Pharma, Inc. |
| Short Percent Of Float | 0.007900001 |
| Short Ratio | 0.76 |
| Source Interval | 15 |
| State | MD |
| Symbol | IGC |
| Target High Price | 5.5 |
| Target Low Price | 3.0 |
| Target Mean Price | 4.25 |
| Target Median Price | 4.25 |
| Total Cash | 235,000 |
| Total Cash Per Share | 0.002 |
| Total Debt | 926,000 |
| Total Revenue | 1,106,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.06 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.31285 |
| Two Hundred Day Average Change | -0.046950012 |
| Two Hundred Day Average Change Percent | -0.15007196 |
| Type Disp | Equity |
| Volume | 508,736 |
| Website | https://igcpharma.com |
| Zip | 20,854 |